Cystic Fibrosis Drugs Market Report

Global and Region Cystic Fibrosis Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：206
  • REPORT CODE：GMM1023732
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The symptoms of cystic fibrosis depend on the organ of the body it affects. For example, if the disease is related to the lungs, the person will experience symptoms such as sputum production and persistent coughing, wheezing, nasal congestion, and recurrent lung infections. Cystic fibrosis has no known cure as of now. There are drugs to treat cystic fibrosis that can help relieve symptoms.

    Over the past few years, the market has grown steadily and has been sustained by the rising prevalence of cystic fibrosis, advances in screening and treatment technology, and rising smoking rates. The Global Cystic Fibrosis Drugs Market will grow at a CAGR of more than 10% during the forecast period 2020-2026.

    Initiatives from governments and other organizations, promising cystic fibrosis treatment pipelines, and market expansion opportunities in emerging countries are providing room for growth in the cystic fibrosis drug market. However, the complex drug development process and expensive treatment options will limit the cystic fibrosis drug market growth.

    The report details the trend, potential and market size of Cystic Fibrosis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cystic Fibrosis Drugsmarket, defines the market attractiveness level of Cystic Fibrosis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cystic Fibrosis Drugs industry, describes the types of Cystic Fibrosis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cystic Fibrosis Drugs market and the development prospects and opportunities of Cystic Fibrosis Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cystic Fibrosis Drugs market in Chapter 13.

    By Player:

    • Pharmaxis

    • Chiesi Farmaceutici

    • Corbus Pharmaceuticals

    • Gilead Sciences

    • United Medical

    • Venus Remedies

    • Merck Sharp & Dohme

    • Insmed

    • Novartis

    • Arcturus Therapeutics

    • Boehringer Ingelheim

    • Novo Nordisk

    • Vertex Pharmaceuticals

    • Abbott

    • Actavis

    • Anthera Pharmaceuticals

    • Proteostasis Therapeutics

    • Neovii Biotech

    • PTC Therapeutics

    • Johnson & Johnson

    • Genzyme

    • PharmaSwiss

    By Type:

    • Oral

    • Injection

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cystic Fibrosis Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cystic Fibrosis Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cystic Fibrosis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cystic Fibrosis Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cystic Fibrosis Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Cystic Fibrosis Drugs Consumption (2017-2022)

    • 7.2 United States Cystic Fibrosis Drugs Consumption (2017-2022)

    • 7.3 Europe Cystic Fibrosis Drugs Consumption (2017-2022)

    • 7.4 China Cystic Fibrosis Drugs Consumption (2017-2022)

    • 7.5 Japan Cystic Fibrosis Drugs Consumption (2017-2022)

    • 7.6 India Cystic Fibrosis Drugs Consumption (2017-2022)

    • 7.7 South Korea Cystic Fibrosis Drugs Consumption (2017-2022)

    8 Region and Country-wise Cystic Fibrosis Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Cystic Fibrosis Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Cystic Fibrosis Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Cystic Fibrosis Drugs Consumption Forecast (2022-2028)

    • 8.4 China Cystic Fibrosis Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Cystic Fibrosis Drugs Consumption Forecast (2022-2028)

    • 8.6 India Cystic Fibrosis Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Cystic Fibrosis Drugs Consumption Forecast (2022-2028)

    9 Global Cystic Fibrosis Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Cystic Fibrosis Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injection Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cystic Fibrosis Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Cystic Fibrosis Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Cystic Fibrosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cystic Fibrosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cystic Fibrosis Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cystic Fibrosis Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cystic Fibrosis Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cystic Fibrosis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cystic Fibrosis Drugs Market Competitive Analysis

    • 14.1 Pharmaxis

      • 14.1.1 Pharmaxis Company Details

      • 14.1.2 Pharmaxis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pharmaxis Cystic Fibrosis Drugs Product and Service

    • 14.2 Chiesi Farmaceutici

      • 14.2.1 Chiesi Farmaceutici Company Details

      • 14.2.2 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Product and Service

    • 14.3 Corbus Pharmaceuticals

      • 14.3.1 Corbus Pharmaceuticals Company Details

      • 14.3.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product and Service

    • 14.4 Gilead Sciences

      • 14.4.1 Gilead Sciences Company Details

      • 14.4.2 Gilead Sciences Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Gilead Sciences Cystic Fibrosis Drugs Product and Service

    • 14.5 United Medical

      • 14.5.1 United Medical Company Details

      • 14.5.2 United Medical Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 United Medical Cystic Fibrosis Drugs Product and Service

    • 14.6 Venus Remedies

      • 14.6.1 Venus Remedies Company Details

      • 14.6.2 Venus Remedies Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Venus Remedies Cystic Fibrosis Drugs Product and Service

    • 14.7 Merck Sharp & Dohme

      • 14.7.1 Merck Sharp & Dohme Company Details

      • 14.7.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Product and Service

    • 14.8 Insmed

      • 14.8.1 Insmed Company Details

      • 14.8.2 Insmed Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Insmed Cystic Fibrosis Drugs Product and Service

    • 14.9 Novartis

      • 14.9.1 Novartis Company Details

      • 14.9.2 Novartis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis Cystic Fibrosis Drugs Product and Service

    • 14.10 Arcturus Therapeutics

      • 14.10.1 Arcturus Therapeutics Company Details

      • 14.10.2 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Arcturus Therapeutics Cystic Fibrosis Drugs Product and Service

    • 14.11 Boehringer Ingelheim

      • 14.11.1 Boehringer Ingelheim Company Details

      • 14.11.2 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Boehringer Ingelheim Cystic Fibrosis Drugs Product and Service

    • 14.12 Novo Nordisk

      • 14.12.1 Novo Nordisk Company Details

      • 14.12.2 Novo Nordisk Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Novo Nordisk Cystic Fibrosis Drugs Product and Service

    • 14.13 Vertex Pharmaceuticals

      • 14.13.1 Vertex Pharmaceuticals Company Details

      • 14.13.2 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product and Service

    • 14.14 Abbott

      • 14.14.1 Abbott Company Details

      • 14.14.2 Abbott Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Abbott Cystic Fibrosis Drugs Product and Service

    • 14.15 Actavis

      • 14.15.1 Actavis Company Details

      • 14.15.2 Actavis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Actavis Cystic Fibrosis Drugs Product and Service

    • 14.16 Anthera Pharmaceuticals

      • 14.16.1 Anthera Pharmaceuticals Company Details

      • 14.16.2 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product and Service

    • 14.17 Proteostasis Therapeutics

      • 14.17.1 Proteostasis Therapeutics Company Details

      • 14.17.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Product and Service

    • 14.18 Neovii Biotech

      • 14.18.1 Neovii Biotech Company Details

      • 14.18.2 Neovii Biotech Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Neovii Biotech Cystic Fibrosis Drugs Product and Service

    • 14.19 PTC Therapeutics

      • 14.19.1 PTC Therapeutics Company Details

      • 14.19.2 PTC Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 PTC Therapeutics Cystic Fibrosis Drugs Product and Service

    • 14.20 Johnson & Johnson

      • 14.20.1 Johnson & Johnson Company Details

      • 14.20.2 Johnson & Johnson Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Johnson & Johnson Cystic Fibrosis Drugs Product and Service

    • 14.21 Genzyme

      • 14.21.1 Genzyme Company Details

      • 14.21.2 Genzyme Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Genzyme Cystic Fibrosis Drugs Product and Service

    • 14.22 PharmaSwiss

      • 14.22.1 PharmaSwiss Company Details

      • 14.22.2 PharmaSwiss Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 PharmaSwiss Cystic Fibrosis Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cystic Fibrosis Drugs

    • Figure Cystic Fibrosis Drugs Picture

    • Table Global Cystic Fibrosis Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cystic Fibrosis Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cystic Fibrosis Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cystic Fibrosis Drugs Consumption by Country (2017-2022)

    • Figure United States Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cystic Fibrosis Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cystic Fibrosis Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Pharmaxis (Foundation Year, Company Profile and etc.)

    • Table Pharmaxis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmaxis Cystic Fibrosis Drugs Product and Service

    • Table Chiesi Farmaceutici (Foundation Year, Company Profile and etc.)

    • Table Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiesi Farmaceutici Cystic Fibrosis Drugs Product and Service

    • Table Corbus Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corbus Pharmaceuticals Cystic Fibrosis Drugs Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Cystic Fibrosis Drugs Product and Service

    • Table United Medical (Foundation Year, Company Profile and etc.)

    • Table United Medical Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table United Medical Cystic Fibrosis Drugs Product and Service

    • Table Venus Remedies (Foundation Year, Company Profile and etc.)

    • Table Venus Remedies Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Venus Remedies Cystic Fibrosis Drugs Product and Service

    • Table Merck Sharp & Dohme (Foundation Year, Company Profile and etc.)

    • Table Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme Cystic Fibrosis Drugs Product and Service

    • Table Insmed (Foundation Year, Company Profile and etc.)

    • Table Insmed Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Insmed Cystic Fibrosis Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Cystic Fibrosis Drugs Product and Service

    • Table Arcturus Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arcturus Therapeutics Cystic Fibrosis Drugs Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Cystic Fibrosis Drugs Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Cystic Fibrosis Drugs Product and Service

    • Table Vertex Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Cystic Fibrosis Drugs Product and Service

    • Table Actavis (Foundation Year, Company Profile and etc.)

    • Table Actavis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis Cystic Fibrosis Drugs Product and Service

    • Table Anthera Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Product and Service

    • Table Proteostasis Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Proteostasis Therapeutics Cystic Fibrosis Drugs Product and Service

    • Table Neovii Biotech (Foundation Year, Company Profile and etc.)

    • Table Neovii Biotech Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neovii Biotech Cystic Fibrosis Drugs Product and Service

    • Table PTC Therapeutics (Foundation Year, Company Profile and etc.)

    • Table PTC Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table PTC Therapeutics Cystic Fibrosis Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Cystic Fibrosis Drugs Product and Service

    • Table Genzyme (Foundation Year, Company Profile and etc.)

    • Table Genzyme Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genzyme Cystic Fibrosis Drugs Product and Service

    • Table PharmaSwiss (Foundation Year, Company Profile and etc.)

    • Table PharmaSwiss Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table PharmaSwiss Cystic Fibrosis Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US